Study of Febrile Thrombocytopenia in Pediatric Patients

Authors

  • Dulari Gandhi
  • Madhav Pandya
  • Hemal Dave
  • Priyanka Gupta
  • Deeksha Suhag
  • Dimple Mehta

DOI:

https://doi.org/10.37591/rrjom.v7i1.1618

Abstract

Background and objectives: Infection is a commonest cause of thrombocytopenia, fever associated with thrombocytopenia helps to narrow differential diagnosis and management of fever. It also helps to know the various complications of thrombocytopenia and its management. Method: 63 patients of fever with decrease platelet count admitted to Pediatrics ward, Dhiraj general hospital, from the time of July 2015 to June 2016. Result: Septicemia was the commonest cause of febrile thrombocytopenia, among malarial species P. vivex is found to be most common. Bleeding manifestations were seen in 17% of patients. 64% of patients had petechiae/purpura as the commonest bleeding manifestation, Good recovery was noted in 89% while 6% had mortality and 5% went DAMA. Dengue VHF and Septicemia accounted for 50% of deaths each. Interpretation and conclusion: Septicemia was the commonest cause of fever with thrombocytopenia. Identification of causative etiology and prompt treatment gives good outcome and avoid the need for platelet transfusion. Mortality is not directly affected by thrombocytopenia

 

Keywords: Fever, thrombocytopenia, septicemia, pediatric, febrile, diagnosis


Cite this Article

Dulari Gandhi, Madhav Pandya, Hemal Dave et al. Study of Febrile Thrombocytopenia in Pediatric Patients. Research & Reviews: Journal of Medicine. 2017; 7(1): 17–20p.


Downloads

Published

2019-06-27

Issue

Vol. 7 No. 1 (2017)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.